ISI Desk

ISI Desk

Although clinical trial data are encouraging, real-world evidence with regard to the COVID-19 vaccine remains scarce. In particular, response to the vaccine among those previously infected with SARS-CoV-2 is still not completely understood. Researchers from Bar-Ilan University and Ziv Medical…

Havas Group today announced the acquisition of full service independent agency, Inbar Merhav G, as part of the Group’s strategic plans in Israel. The agency will rebrand to Havas Inbar Merhav G Ltd. Founded in 1999 and headquartered in Tel…